Suppliers
Cardiac Stents and Balloons
(Switzerland)
Develop, manufacture and market innovative medical devices for interventional cardiology and critical care procedures. With a focus on improving patient outcomes today, while driving the development of tomorrow’s next-generation medical technology, Biosensors has become over the last two-decade a leader in the global coronary stent market. Beyond a strong foothold in cardiovascular devices and critical care products, the company has more recently entered new therapeutic areas as Endovascular and cardiac imaging with enhanced devices and systems.
Epilepsy Treatment System (VNS)
(USA)
A sharply innovative and progressive medical device company with core expertise in neuromodulation. Its mission is to improve the lives of people touched by epilepsy, depression and other chronic disorders that may prove treatable with their patented therapy, Vagus Nerve Stimulation (VNS) Therapy system, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy system uses a surgically implanted medical device that delivers pulsed electrical signals to the vagus nerve.
Endovascular & Neurovascular Products
(USA)
A global leader and technology provider for specialists treating a wide range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular markets offering a comprehensive portfolio of treatment options, including the primary interventional technologies used today - peripheral angioplasty balloons, stents, plaque excision systems, embolic protection devices, liquid embolics, embolization coils, flow diversion, thrombectomy catheters and occlusion balloons.
Spinal Devices
(USA)
Dedicated to spinal implants with blockbuster products and has a long experience addressing a tailored response to each patient case and surgeon needs. The company is founded on science-based innovation, outcome oriented research, and a strong commitment to education worldwide. The Company was the first to introduce PEEK implants to spinal surgery as well as posterior dynamic stabilization technology.
Neurosurgery Valves
(France)
Sophysa is the largest European shunt manufacturer for hydrocephalus treatment. With its great experience in the development of micro-mechanisms and implantable materials, Sophysa markets technically advanced solutions to serve the needs of healthcare providers and patients in three areas: Neurosurgery, Intensive Care Unit and Chemotherapy.
